Kemwell is a contract biologics development and CMO company providing services to global biologics organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing.
How can we make the Indian Pharma Manufactures Atmanirbhar in a true way?
The government plans to develop three mega bulk drug parks, which will be set up at a cost of Rs 14,300 Cr in association with various states to produce chemicals for life-saving drugs and reduce their imports from China.
Kemwell Biopharma increases capacity for manufacturing of biologics
The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical toxicology batch and early cGMP clinical trial supplies at 250L to 1000L scale in its current facility
Bengaluru based Kemwell Biopharma, a biologics contract development and manufacturing service provider, has recently augmented its existing infrastructure. As part of this expansion strategy, the company has installed Ambr® 250, a high throughput equipment with 12 fully automated mini bioreactors at a 250 ml scale to accelerate process development.
We are professional and reliable provider since we offer customers the most powerful and beautiful themes. Besides, we always catch the latest technology and adapt to follow world’s new trends to deliver the best themes to the market.
Read More ->